Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Mulder

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
The Journal of Pathology|March 1, 1996
Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasmsI O Baas, F M van den Berg, J W Mulder, et al.
Antiviral Therapy|April 1, 1997
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.
AIDS (London, England)|December 24, 1998
Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individualsR M Hoetelmans, R P van Heeswijk, M Profijt, et al.
British Journal of Haematology|November 1, 1992
Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual menG H Mientjes, E J van Ameijden, J W Mulder, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
Journal of Thrombosis and Haemostasis : JTH|June 24, 2011
Influenza vaccination and hemostasis: no sustainable procoagulant effects from 2009 H1N1 influenza vaccine in healthy healthcare workersP M Smit, S Veldhuis, J W Mulder, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 24, 2009
Identification and profiling of circulating metabolites of atazanavir, a HIV protease inhibitorR ter Heine, M J X Hillebrand, H Rosing, et al.
Lancet (London, England)|September 8, 1990
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyC A Boucher, M Tersmette, J M Lange, et al.
The Journal of Pediatrics|November 1, 1991
Risk of hepatoblastoma in familial adenomatous polyposisF M Giardiello, G J Offerhaus, A J Krush, et al.
AIDS (London, England)|March 29, 2001
Drug interaction between St John's wort and nevirapineM M de Maat, R M Hoetelmans, R A Math t, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
The Journal of Pathology|March 1, 1996
Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasmsI O Baas, F M van den Berg, J W Mulder, et al.
Antiviral Therapy|April 1, 1997
HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrierD M Burger, C A Boucher, P L Meenhorst, et al.
AIDS (London, England)|December 24, 1998
Comparison of the plasma pharmacokinetics and renal clearance of didanosine during once and twice daily dosing in HIV-1 infected individualsR M Hoetelmans, R P van Heeswijk, M Profijt, et al.
British Journal of Haematology|November 1, 1992
Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual menG H Mientjes, E J van Ameijden, J W Mulder, et al.
AIDS (London, England)|December 1, 1994
Pharmacokinetic variability of zidovudine in HIV-infected individuals: subgroup analysis and drug interactionsD M Burger, P L Meenhorst, C H ten Napel, et al.
Journal of Thrombosis and Haemostasis : JTH|June 24, 2011
Influenza vaccination and hemostasis: no sustainable procoagulant effects from 2009 H1N1 influenza vaccine in healthy healthcare workersP M Smit, S Veldhuis, J W Mulder, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 24, 2009
Identification and profiling of circulating metabolites of atazanavir, a HIV protease inhibitorR ter Heine, M J X Hillebrand, H Rosing, et al.
Lancet (London, England)|September 8, 1990
Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyC A Boucher, M Tersmette, J M Lange, et al.
The Journal of Pediatrics|November 1, 1991
Risk of hepatoblastoma in familial adenomatous polyposisF M Giardiello, G J Offerhaus, A J Krush, et al.
AIDS (London, England)|March 29, 2001
Drug interaction between St John's wort and nevirapineM M de Maat, R M Hoetelmans, R A Math t, et al.
Pageof 15